Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 340

1.

Wild-type and splice-variant secretin receptors in lung cancer: overexpression in carcinoid tumors and peritumoral lung tissue.

Körner MU, Hayes GM, Carrigan PE, Rehmann R, Miller LJ, Reubi JC.

Mod Pathol. 2008 Apr;21(4):387-95. doi: 10.1038/modpathol.3801005. Epub 2008 Jan 25.

PMID:
18223557
[PubMed - indexed for MEDLINE]
Free Article
2.

Secretin receptors in the human liver: expression in biliary tract and cholangiocarcinoma, but not in hepatocytes or hepatocellular carcinoma.

Körner M, Hayes GM, Rehmann R, Zimmermann A, Scholz A, Wiedenmann B, Miller LJ, Reubi JC.

J Hepatol. 2006 Dec;45(6):825-35. Epub 2006 Jul 28.

PMID:
16935383
[PubMed - indexed for MEDLINE]
3.

Secretin receptors in normal and diseased human pancreas: marked reduction of receptor binding in ductal neoplasia.

Körner M, Hayes GM, Rehmann R, Zimmermann A, Friess H, Miller LJ, Reubi JC.

Am J Pathol. 2005 Oct;167(4):959-68.

PMID:
16192632
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

A novel secretin receptor splice variant potentially useful for early diagnosis of pancreatic carcinoma.

Hayes GM, Carrigan PE, Dong M, Reubi JC, Miller LJ.

Gastroenterology. 2007 Sep;133(3):853-61. Epub 2007 Jun 20.

PMID:
17678920
[PubMed - indexed for MEDLINE]
5.

Silencing of secretin receptor function by dimerization with a misspliced variant secretin receptor in ductal pancreatic adenocarcinoma.

Ding WQ, Cheng ZJ, McElhiney J, Kuntz SM, Miller LJ.

Cancer Res. 2002 Sep 15;62(18):5223-9.

PMID:
12234988
[PubMed - indexed for MEDLINE]
Free Article
6.

Correlative immunohistochemical and reverse transcriptase polymerase chain reaction analysis of somatostatin receptor type 2 in neuroendocrine tumors of the lung.

Papotti M, Croce S, Macrì L, Funaro A, Pecchioni C, Schindler M, Bussolati G.

Diagn Mol Pathol. 2000 Mar;9(1):47-57.

PMID:
10718213
[PubMed - indexed for MEDLINE]
7.

Ghrelin and cortistatin in lung cancer: expression of peptides and related receptors in human primary tumors and in vitro effect on the H345 small cell carcinoma cell line.

Cassoni P, Allia E, Marrocco T, Ghè C, Ghigo E, Muccioli G, Papotti M.

J Endocrinol Invest. 2006 Oct;29(9):781-90.

PMID:
17114908
[PubMed - indexed for MEDLINE]
8.

Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene.

Tao Q, Fujimoto J, Men T, Ye X, Deng J, Lacroix L, Clifford JL, Mao L, Van Pelt CS, Lee JJ, Lotan D, Lotan R.

J Natl Cancer Inst. 2007 Nov 21;99(22):1668-82. Epub 2007 Nov 13.

PMID:
18000218
[PubMed - indexed for MEDLINE]
Free Article
9.

Expression of somatostatin receptors in peritumoral veins of human tumors.

Denzler B, Reubi JC.

Cancer. 1999 Jan 1;85(1):188-98.

PMID:
9921992
[PubMed - indexed for MEDLINE]
10.

Dominant negative action of an abnormal secretin receptor arising from mRNA missplicing in a gastrinoma.

Ding WQ, Kuntz S, Böhmig M, Wiedenmann B, Miller LJ.

Gastroenterology. 2002 Feb;122(2):500-11.

PMID:
11832464
[PubMed - indexed for MEDLINE]
11.
12.

High density of somatostatin receptors in veins surrounding human cancer tissue: role in tumor-host interaction?

Reubi JC, Horisberger U, Laissue J.

Int J Cancer. 1994 Mar 1;56(5):681-8.

PMID:
8314345
[PubMed - indexed for MEDLINE]
13.

Molecular characterization of the human delta opioid receptor in lung cancer.

Schreiber G, Campa MJ, Prabhakar S, O'Briant K, Bepler G, Patz EF Jr.

Anticancer Res. 1998 May-Jun;18(3A):1787-92.

PMID:
9673405
[PubMed - indexed for MEDLINE]
14.

Bombesin receptor subtypes in human cancers: detection with the universal radioligand (125)I-[D-TYR(6), beta-ALA(11), PHE(13), NLE(14)] bombesin(6-14).

Reubi JC, Wenger S, Schmuckli-Maurer J, Schaer JC, Gugger M.

Clin Cancer Res. 2002 Apr;8(4):1139-46.

PMID:
11948125
[PubMed - indexed for MEDLINE]
Free Article
15.

ED-B fibronectin in non-small cell lung carcinoma.

Khan ZA, Caurtero J, Barbin YP, Chan BM, Uniyal S, Chakrabarti S.

Exp Lung Res. 2005 Sep;31(7):701-11.

PMID:
16203624
[PubMed - indexed for MEDLINE]
16.

Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas.

Reubi JC, Kvols LK, Waser B, Nagorney DM, Heitz PU, Charboneau JW, Reading CC, Moertel C.

Cancer Res. 1990 Sep 15;50(18):5969-77.

PMID:
2168286
[PubMed - indexed for MEDLINE]
Free Article
17.

Characterization of SEZ6L2 cell-surface protein as a novel prognostic marker for lung cancer.

Ishikawa N, Daigo Y, Takano A, Taniwaki M, Kato T, Tanaka S, Yasui W, Takeshima Y, Inai K, Nishimura H, Tsuchiya E, Kohno N, Nakamura Y.

Cancer Sci. 2006 Aug;97(8):737-45.

PMID:
16863507
[PubMed - indexed for MEDLINE]
18.

Expression of somatostatin receptors in normal, inflamed, and neoplastic human gastrointestinal tissues.

Reubi JC, Laissue J, Waser B, Horisberger U, Schaer JC.

Ann N Y Acad Sci. 1994 Sep 15;733:122-37. Review.

PMID:
7978860
[PubMed - indexed for MEDLINE]
19.

Interleukin 4 receptor expression on human lung tumors and normal lung.

Tungekar MF, Turley H, Dunnill MS, Gatter KC, Ritter MA, Harris AL.

Cancer Res. 1991 Jan 1;51(1):261-4.

PMID:
1846310
[PubMed - indexed for MEDLINE]
Free Article
20.

Secretin receptor promotes the proliferation of endocrine tumor cells via the PI3K/AKT pathway.

Lee M, Waser B, Reubi JC, Pellegata NS.

Mol Endocrinol. 2012 Aug;26(8):1394-405. doi: 10.1210/me.2012-1055. Epub 2012 Jun 12.

PMID:
22692904
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk